Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC
Supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Pain is responsible for most visits to health care providers, and yet many providers are not entirely confident in their ability to manage pain. This interactive, case-based, and adaptive program can help learners improve their knowledge of pain management, including how and when to safely use opioid medications. Initially, learners are presented with brief patient vignettes, followed by question to assess knowledge in specific domains. Each learner’s responses to these questions will then inform a customized curriculum that addresses the identified knowledge gaps.
The curriculum is based on the FDA’s Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain.
Michael R. Clark, MD, MPH, MBA
Chair, Psychiatry & Behavior Health
Inova Health System
Falls Church, VA
Michael R. Clark is the Chair of Psychiatry and Behavioral Health for the Inova Health System. He oversees all aspects of the service line including clinical programs, educational initiatives, research projects, and departmental operations reporting directly to the Chief Medical Officer. Previously, Dr. Clark was the Vice Chair for Clinical Affairs in the Department of Psychiatry & Behavioral Sciences at the Johns Hopkins University School of Medicine for 5 years following his position as Medical Director for Global Services in Johns Hopkins Medicine International for 4 years. His responsibilities included medical quality, patient safety, clinical productivity, knowledge transfer, and financial operations across a range of settings (academic medical centers, community hospitals, international affiliates) focusing on strategic planning.
Dr. Clark is an Associate Professor at The Johns Hopkins University School of Medicine in Baltimore, Maryland. He is trained as a consultation-liaison psychiatrist with subspecialization in disorders of the special senses such as chronic pain and vestibular & balance dysfunction. He has conducted clinical research in these areas and developed interdisciplinary clinical programs for patients suffering from these disorders.
Dr. Clark was the Director of the Adolf Meyer Chronic Pain Treatment Programs in the Department of Psychiatry & Behavioral Sciences and has joint appointments in the Department of Otolaryngology - Head & Neck Surgery in the School of Medicine and in the Department of Mental Health in the Bloomberg School of Public Health at the Johns Hopkins University. He is an international lecturer and course director for CME programs on topics relating to patient-centered care, case formulation, rehabilitation for chronic illnesses, interdisciplinary program building, and concepts of medical education.
Dr. Clark received his MD from Washington University School of Medicine in St. Louis, Missouri and his MPH from the Department of Epidemiology at the University of Washington School of Public Health in Seattle, Washington. He completed his internship and residency in psychiatry and behavioral sciences at The Johns Hopkins Medical Institutions and his fellowship in consultation-liaison psychiatry at the University of Washington School of Medicine. Dr. Clark received his MBA from The Johns Hopkins University School of Professional Studies in Business and Education.
A fellow of the Academy of Psychosomatic Medicine, Dr. Clark currently devotes his research to the formulation and care of the psychiatric aspects of somatic symptoms such as chronic pain, including studies on health services delivery, pharmacological treatment of neuropathic pain, substance abuse, and the phenomenology of depression in chronic illness. He served on the National Institutes of Health Division of Research Grants Risk Prevention and Health Behavior Study Section for over 15 years. He has consulted as an expert for the U.S. Department of Defense in the design of the Gulf War Specialized Health Care Centers.
Yvonne D’Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse Practitioner
Ponte Vedra Beach, FL
Yvonne M. D’Arcy is a pain management and palliative care nurse practitioner with 20 years of clinical experience. She practiced most recently at Suburban Hospital-Johns Hopkins Medicine in Bethesda, Maryland. Prior to her work at Suburban Hospital, Ms. D'Arcy was the coordinator of the Acute Pain Service and the Supervisor of the Chronic Pain Clinic at Mayo Clinic Jacksonville FL. Ms. D’Arcy received her nursing education at Viterbo University in La Crosse, Wisconsin, and Winona State University in Winona, Minnesota.
Ms. D’Arcy is a member of a number of professional societies, including the American Association of Nurse Practitioners where she was recently inducted as a Fellow. She is currently serving as Co-Chair of the AANP Pain Management Special Practice Group. She serves on the editorial boards for such journals as the Journal for Nurse Practitioners, Nursing2019, and Pain Management News.
Ms. D’Arcy has authored or co-authored more than 100 articles and 7 books, including the award-winning Compact Clinical Guide to Cancer Pain Management: An Evidence-Based Approach for Nurses, How to Manage Pain in the Elderly, and How to Manage Pain in Addicted Patients. She has given more than 170 presentations at facilities and professional society meetings nationwide.
Jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
*To claim and receive MOC credits, learners must email email@example.com and provide (a) ABIM ID number, (b) first and last name, (c) degree and specialty, (d) DOB (month and day), and (e) activity completion date.
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.75 contact hours. Designated for a maximum of 2.75 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Michael R. Clark, MD, MPH, MBA: no disclosures
Yvonne D’Arcy, MS, ARNP-C, CNS, FAANP has received royalties from Springer Publishing, and honoraris from GlaxoSmithKline, Pfizer, Salix Pharmaceuticals and Ortho-McNeil Pharmaceuticals.
The PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above